Predictors of Prostate Cancer After Initial Negative Systematic 12 Core Biopsy

Gore, 2001, Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer, J Urol, 165, 1554, 10.1016/S0022-5347(05)66347-1

Chon, 2002, Use of extended systematic sampling in patients with a prior negative prostate needle biopsy, J Urol, 167, 2457, 10.1016/S0022-5347(05)65004-5

Stewart, 2001, Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies, J Urol, 166, 86, 10.1016/S0022-5347(05)66083-1

Catalona, 1998, Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial, JAMA, 279, 1542, 10.1001/jama.279.19.1542

Catalona, 1991, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702

Carter, 1997, Prostate-specific antigen velocity and repeated measures of prostate-specific antigen, Urol Clin North Am, 24, 333, 10.1016/S0094-0143(05)70380-3

Djavan, 2000, Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men, J Urol, 163, 1144, 10.1016/S0022-5347(05)67711-7

Catalona, 1997, Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies, J Urol, 158, 2162, 10.1016/S0022-5347(01)68187-4

Presti, 2003, Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study, J Urol, 169, 125, 10.1016/S0022-5347(05)64051-7

McNeal, 1986, Intraductal dysplasia: a premalignant lesion of the prostate, Hum Pathol, 17, 64, 10.1016/S0046-8177(86)80156-3

Fowler, 2000, Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer, J Urol, 163, 813, 10.1016/S0022-5347(05)67810-X

Lefkowitz, 2002, Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels, J Urol, 168, 1415, 10.1016/S0022-5347(05)64463-1

Mian, 2002, Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy, Urology, 60, 836, 10.1016/S0090-4295(02)01950-7

Iczkowski, 2002, Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy, Urology, 60, 851, 10.1016/S0090-4295(02)01981-7

Bazinet, 1996, Value of systematic transition zone biopsies in the early detection of prostate cancer, J Urol, 155, 605, 10.1016/S0022-5347(01)66463-2

Morote, 1999, Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time, Eur Urol, 35, 294, 10.1159/000019864

Singh, 2004, Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy, J Urol, 171, 204, 10.1097/01.ju.0000100220.46419.8b

Nixon, 1998, Comparison of 3 investigational assays for the free form of prostate specific antigen, J Urol, 160, 420, 10.1016/S0022-5347(01)62913-6